Difference between revisions of "Part:BBa K1323002"

Line 5: Line 5:
  
 
This part was DNA-Synthesized.
 
This part was DNA-Synthesized.
 
 
 
 
  
  
Line 17: Line 13:
 
<span class='h3bb'>Sequence and Features</span>
 
<span class='h3bb'>Sequence and Features</span>
 
<partinfo>BBa_K1323002 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K1323002 SequenceAndFeatures</partinfo>
 +
  
 
==References==
 
==References==

Revision as of 04:04, 17 October 2014

dCas9: Expression cassette under a xylose inducible promoter

dCas9 or ‘dead’ cas9 is a mutated version of Cas9 that has lost its endonuclease activity - it no longer cuts double stranded DNA, instead simply binding to it. This means it can function as a repressor after complexing with sgRNA and the sgRNA-target site. dCas9 contains mutations in the RuvC1 and HNH nuclease domains; these changes are what bestow this modified Cas9 with it’s ability to bind DNA instead of cleaving it (Lei S. Qi, 2013). It has a Xylose Inducible Promoter BBa_K1323014 and a sodA RBS BBa_K1323022. The illegal sites have been removed, and the sequence was codon optimized for expression in S. epidermidis using JCat software.

This part was DNA-Synthesized.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 1476
    Illegal BamHI site found at 4894
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


References

Lei S. Qi, M. H. (2013). Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell, 1173-1183.